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Summary Background: Knowledge of allergy patients’ perception of own disease is
inadequate, and understanding of the impact of local environment, including family
and health-care system, on patients’ management of disease is insufficient. We
examined the potential of telephone-based survey techniques for establishing this
knowledge in 10 European countries.
Methods: A two-phased questionnaire developed by use of focus groups in seven
countries was translated into 10 languages. To ensure that the true values of the
populations were restored in randomly selected populations, 75 343 telephone numbers
selected for screening represented balanced national distributions of households.
Results: Eight thousand two hundred and sixty-eight respiratory allergy sufferers
were identified by the telephone screening process. 85.4% accepted to participate in
the survey and 89.6% completed both phases comprising 34 questions and rating of
49 statements. Data for each country were weighted in terms of age, sex and the
recorded allergy prevalence within age intervals.
Conclusions: The telephone survey technique allowed for establishment of random
representative samples, and application of mathematical weighting procedures assured
that the true national values were restored in the data set. As all interviews were
performed in a standardised manner we conclude that the telephone-based survey
methodology enables national representative data set to be established and compared.
& 2003 Elsevier Ltd. All rights reserved.
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Introduction
Research within allergy is intense and studies
addressing aspects of immunology,1–3 symptoms4,5
and treatment6–8 are reported continually. Despite
this, the knowledge of the allergy patient’s
perception of own disease and of its consequences
is scarce. Moreover, the understanding of the
impact of local environment, including family and
national health-care systems, on the patient’s
management of own disease is insufficient.
In this paper, we describe a study on the European
allergy patients’ own perception of allergy and of
life with a derived respiratory disease. It is the first
time that allergic people have been addressed
directly and cross-nationally with the objective of
obtaining information about their perception of
allergy and their life with this disease.
The aims of this study called ‘‘AllergyFLiving &
Learning’’ were to (1) evaluate the prevalence of
respiratory allergic diseases in the population of 10
European countries by national screening of random
and representative populations, (2) identify which
factors are important to the allergic patient’s
perception and management of own respiratory
disease and influence on social life, (3) investigate
the potential consequences of specific diagnosis and
treatment for the patient and (4) make comparisons
between the 10 European countries included. Con-
sequently, the study included both patients with an
objective medical diagnosis and those without.
This paper describes the method applied and its
feasibility, especially the selection of study popula-
tion and the development and validation of the
questionnaire used in the investigation.
In principle, the AllergyFLiving & Learning study
consisted of three phases, a qualitative study, a pre-
testing phase, and a quantitative study. In the
qualitative phase, a specific instrument was devel-
oped, i.e. a questionnaire, by means of interviews of
allergy patient focus groups. Phase two embraced
pre-testing, translations into 10 European languages
and linguistic validation. In the quantitative phase,
7000 patients with asthma and hay fever were
identified from 10 European countries, i.e. Austria,
Denmark, Finland, Germany, Italy, the Netherlands,
Norway, Spain, Sweden and the United Kingdom.
Materials and methods
The European Advisory Board (EAB)
The study was initiated, co-ordinated and super-
vised by an international advisory board, the EAB,
consisting of physicians, scientists and representa-
tives from European patient organisations including
the European Federation of Asthma and Allergy
(EFA). The EAB was responsible for the develop-
ment of the questionnaire and the study protocol,
for the conduct of the study, for the data analyses
and for the reporting. No EAB member was involved
in the study, neither as investigator nor as
participant.
Study design
The AllergyFLiving & Learning project consisted of
three phases, as outlined in Fig. 1.
In phase one, the EAB developed guidelines for
the focus group interviews in co-operation with
psychologists experienced in conducting group
interviews and handling focus groups. These guide-
lines aimed at identifying issues to be included in
the quantitative phase and exploring their rele-
vance at a European level. Focus group interviews
were held in seven countries, each group consisting
of 7 to 11 allergic patients. Based on these results,
the EAB developed a questionnaire and a procedure
for telephone interviewing, including the issues
identified as important to the allergic patient.
The interviews were divided into three steps: a
telephone interview, a self-completion of a ques-
tionnaire, and a second telephone interview to
collect the answers from the self-completed ques-
tionnaires. The first telephone call aimed at
collecting the factual information; whereas the
postal questionnaire contained complex statements
to be rated.
Phase two comprised a pilot test of the ques-
tionnaire, followed by revisions, translation into 10
European languages, and linguistic validation. In
phase three, the quantitative phase, 7004 inter-
views were carried out in 10 European countries.
Ethical standards
The focus group interviews, the pilot test inter-
views and the quantitative pan-European study
were conducted in accordance with the Code of
Conduct of the European Standards of Market
Analysis and Research (ESOMAR, Amsterdam, the
Netherlands). This code of conduct guarantees the
full anonymity and integrity of the respondents.
Interviews
The focus group interviews, the pilot testing and
the quantitative interviewing were performed by a
global market survey institute with local represen-
tations in the countries in question (ACNielsen AIM,
Copenhagen, Denmark).
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The population
The target population aged 16–60 years was
identified by telephone screening of random,
national, representative samples of telephone
numbers. The study inclusion criteria were a
positive reporting of respiratory allergy to pollen
(i.e. trees, grasses or weeds), house dust mites,
moulds, dog, cat or other animals and, concomi-
tantly, a description of appropriate symptoms, see
Fig. 2. In order to be eligible for participation,
though asked, the respondent should not necessa-
rily be able to report the medical diagnosis as, e.g.
rhinitis or hay fever. Consequently, the full popula-
tion included in the AllergyFLiving & Learning
study reported to be suffering from a respiratory
allergy, irrespective of the degree of symptoms.
The study did not include children to avoid the
bias when parents answer on behalf of their
children. People older than 60 years of age were
not included as they often have non-allergic
respiratory conditions that mimic allergic respira-
tory disorders.
In order to minimise bias and to obtain a truly
random sample, the interviewer first asked to talk
to the person in the household whose birthday was
next to come around. In case this person was
unavailable, up to six more calls were made in
order to establish contact. The respondent was not
informed about purpose and scope of the interview
when completing the screening phase. If the initial
respondent did not fulfil the inclusion criteria in the
screening phase, another person in the household
could be requested to complete the screening
phase.
The qualitative phase
Study set-up
The focus groups consisted of 7 to 11 allergic
patients aged 18–60 years. People participating in
focus groups must be at least 18 years of age
according to legal restrictions and the ESOMAR
guidelines. Focus group participants were identi-
fied as described above and they gave written
consent prior to the interview. They were brought
together in a major town in Denmark, England,
Germany, Italy, the Netherlands, Spain or Sweden.
A psychologist from the individual country con-
ducted the group interview in accordance with the
master discussion guide. A leading psychologist
supervised all interviews and briefed the local
moderators thoroughly prior to each of the inter-
views. Additionally, each session was videotaped.
Immediately after the sessions, participants were
debriefed by the psychologist and could watch the
videotape.
Analysis
The team of psychologists interpreted the results
represented by focus group participants’ state-
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Figure 1 The AllergyFLiving & Learning study design.
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ments and reactions and reported the findings in
national reports, written in English. The main
findings were gathered in a trans-national report.
Focus group results
Sixty-eight respiratory allergics participated in
seven focus groups. The focus group results
disclosed that the perceived restrictions on and
problems of persons with allergy are very similar
irrespective of nationality, the specific allergy and
the allergic disease. Subsequently, the results
indicated that the issues of relevance to the
allergic population were shared in all participating
countries.
In general, focus group participants reported
that allergy was neither accepted as a real disease
by general physicians nor by friends and family.
Additionally, all focus groups reported that self-
medication was standard as the professional advice
was perceived to be of little or even no value.
Furthermore, a critical need for more information
about allergy and allergic diseases was present but
unmet by health-care systems and patient organi-
sations.
Moreover, all focus group participants said that
the presence of social and psychological problems
was caused by lack of acceptance of their disease
by family and friends, a feeling of being unattrac-
tive when experiencing symptoms and a feeling of
isolation both at work and socially.
Based on the focus group results, the EAB
prepared an instrument, i.e. a questionnaire, for
the quantitative phase addressing the aspects
identified as important. This questionnaire com-
prised three parts: eight categorising questions
about, e.g. income and level of education, 32
multiple-choice questions addressing perception of
allergy, allergy triggers, specific diagnoses,
symptoms, disease management and knowledge of
own disease as well as the rating of 54 state-
ments concerning symptoms, restrictions and
social functioning. The first two parts of the
questionnaire were to be answered immediately
during the first telephone contact, whereas the
third part containing the rating of statements was
to be forwarded in writing by post, and the answers
were subsequently collected by a second telephone
call.
The pre-testing phase
Study set-up
Phase two embraced pilot testing of the question-
naire, translation into 10 European languages and
linguistic validation.
In January 1999, the questionnaire was tested in
50 telephone interviews in Denmark. In this pilot
test, only the person in the household whose
birthday was next to come around was screened.
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Figure 2 Study inclusion criteria were the positive reporting of respiratory allergy to pollen (e.g. trees, grasses or
weeds), house dust mites, moulds, dog, cat or other animal, and, concomitantly, a description of appropriate
symptoms.
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Upon completion of the questionnaire, the
respondents were asked to comment both specifi-
cally and freely on the questions.
Based on the results of the pilot test and the
comments, the questionnaire underwent modifica-
tions and the EAB signed off on an English master
questionnaire. In each country, a professional,
native translator translated the master into the
nine other European languages of relevance and
had the interpreted questionnaire verified by a
local specialist familiar with allergy terminology.
The local questionnaires were then collected and
professionally translated back into English by a
translation agency (Communicare, London, Eng-
land). These translations were then compared with
the master questionnaire, and the local translator
and the local EAB member corrected any discre-
pancy before final acceptance.
Pre-testing results
The telephone statistics of the pilot test are shown
in Table 1. A total of 268 telephone calls were made
in a telephone screening of a random, representa-
tive sample of Danish telephone numbers in order
to identify 50 positively screened allergics who
accepted to complete the questionnaire. An esti-
mate of the Danish prevalence of perceived
respiratory allergy was 18.7%. Ninety per cent of
those accepting to answer the questionnaire
completed the full questionnaire indicating that
the telephone–postal–telephone procedure worked
well. Based on an evaluation of non-response
items, direct correlation between questions, the
time for completion of the full interview and of
comments/input from respondents, the question-
naire was modified slightly by the EAB. Upon
revision, the questionnaire was reduced to com-
prise six categorising questions, 28 multiple-choice
questions, and the rating of 49 statements. Lastly,
the database into which the responses were
entered worked well as free cross-tabulations could
be made and any sub-population could be con-
structed and characterised.
Sample size and statistical methods
Sample sizes were determined based on an ex-
pected minimum prevalence of respiratory allergic
diseases of 10% and a Gaussian distribution of the
population. Thus, the 95% confidence interval
around any such estimate is given by
71:96
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
pð100 pÞ=N
p
:
It was assumed that 80% of the respondents
completing the first part of the interview would
finish the full questionnaire. The national samples
were chosen accordingly to contain a minimum of
500 respondents in order to obtain appropriate
statistical power of all questions. In Finland,
Sweden, Norway, Denmark, Austria and the Nether-
lands the national samples were 500. As a large
population and extent geography may constitute
sources of variation, national samples of Germany,
the United Kingdom, Italy and Spain were 1000.
The quantitative phase
Study set-up
In each country, the local survey institute chose a
person responsible for the survey and a group of
four to six native speaking and experienced inter-
viewers. They were all briefed thoroughly in
relation to allergy and related local terminology.
Additionally, each interviewer was accustomed to
the use of the questionnaire prior to performing the
real interviews. In order to maintain standards and
a uniform approach, the person responsible for the
survey covertly listened in on the interviews and
corrected during the data collection, if necessary.
The interviewers read the questions to the
respondent from a computer monitor, and the
answers were computerised online as the inter-
viewer immediately entered each answer into the
database. All multiple-choice options were rando-
mised by the computer when presented to the
respondent. Technically, it was made impossible to
provide answers with built-in contradictions, e.g.
did the respondent inform the interviewer that s/
he did not take medicine, s/he could not claim use
of nasal sprays without changing the first input.
Classification questions about income, education
and geographical region were country specific and
varied in accordance with national standards.
The average duration of the first telephone
interview including screening was approximately
15min. Collection of responses to the self-comple-
tion questionnaire (second telephone interview)
took approximately 6min; however, the amount of
time each respondent spent on the self-completion
questionnaire is unknown.
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Table 1 Telephone statistics from the pilot study
Number of calls ðNÞ 268
Number of positive screenings,P
1st
  50
Number completing 1st interview 50
Number completing 2nd
interview,
P
2nd
  45
Prevalence estimate
P
1st=N
 
50
268 ¼ 18:7%
Completion estimateP
2nd=
P
1st
 
45
50 ¼ 90:0%
408 J. de Monchy et al.
The screening and the performance of the first
interview were distributed evenly during 3 months,
starting on 1 March 1999. Each interview–postal–
interview procedure should not exceed 2 weeks,
and consequently the total data collection was
completed by 15 June 1999.
Data management, weighting and analysis
The data were entered into a database nationally
as the responses were collected. The entry of the
data was checked both locally and centrally by re-
coding data to eliminate inconsistent responses.
In order to ensure that the values of the true
population were restored in the randomly selected
population, the telephone numbers selected for
screening represented a geographical balanced
national distribution of households. The official
records of age and sex distributions of each country
were accessed and national weighting matrices
were set up for the three age intervals, and for the
sex distribution of each interval. Then, the data for
each country were weighted in terms of age, sex
and the recorded allergy prevalence within three
age intervals of 16–29, 30–49 and 50–60 years.
Results
The telephone statistics of the quantitative study
are shown in Table 2. A total of 75 343 different
telephone numbers were identified from random
selected national representative samples from
which 8268 perceived respiratory allergy sufferers
were identified. 7065 accepted the invitation to
participate in the study and 1204 declined repre-
senting an initial refusal rate of 14.6%. Sixty-one
entries were deleted due to inconsistent responses
after completion of the interviewing.
The allergics’ initial refusal rate varied signifi-
cantly among countries from 0.6% in Germany to
30.8% in Norway. Upon completion of the interview
in the first telephone interviews and after receipt
of the written questionnaire, 733 of the partici-
pants declined to participate in the second tele-
phone interview representing a secondary refusal
rate of 10.4% varying between 19.0% in Austria and
1.0% in Germany. The number of respondents
completing both parts of the AllergyFLiving &
Learning questionnaire was 6331 of the 7004
entering the study.
Relatively, Spain and Austria were the countries
in which most calls were needed to obtain the
required number of respondents. In Spain, it was a
general problem to reach people by phone when
comparing with other countries, and in Austria, the
population is less inclined to participate in surveys.
The allergics’ initial refusal rates in Italy and
Norway were 27.5% and 30.8%, respectively, and
significantly higher than that of any other country
included. In general, the relative surplus of
refusers in Italy and Norway was recorded when
the potential participants were informed that they
were to receive a written questionnaire and
therefore should provide information about name
and address. Though emphasising that there would
be kept no record of personal information including
name, address and telephone number, experience
shows that the employment of written contact
increases the refusal rate dramatically in these two
countries.
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Table 2 Telephone statistics from the quantitative study in 10 European countries
Number
sample
Negativen Net
sample
Allergic
refusers
Allergic
refusers (%)
1st
interview
Refuse 2nd
interview
2nd
interview
2nd/1st
interview (%)
Denmark 4573 4033 540 39 7.2 502 32 470 93.6
UK 9329 8291 1038 44 4.2 994 159 835 84.0
Sweden 2359 1760 599 100 16.7 499 51 448 89.8
Norway 4575 3842 733 226 30.8 507 74 433 85.4
Finland 5484 4893 591 83 14.0 508 47 461 90.7
Germany 7169 6162 1007 6 0.6 1001 10 991 99.0
Austria 14 182 13 596 586 90 15.4 496 94 402 81.0
The
Netherlands
5909 5305 604 56 9.3 548 42 506 92.3
Italy 6380 4989 1391 383 27.5 1008 123 885 87.8
Spain 15 383 14 204 1179 177 15.0 1002 101 901 89.9
Total 75 343 67 075 8268 1204 14.6 7065w 733 6332 89.6
nIncludes: no contact, refuse at contact or no positive screenings.
w61 entries were deleted after the interview was complete.
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The highest rate of secondary refusal was
recorded in Austria where a high tendency to
refuse participation in surveys in generally is
present.
Distributions of data according to age and sex are
shown in Table 3, including the distributions after
mathematical weighting in respect to each coun-
try’s true distribution of age, gender and the
relative weight of respiratory allergy measured in
the three age intervals. Men and younger people
were underrepresented in the population, as the
refusal rate generally was higher among men, and
younger people were more difficult to contact at
home. This is in accordance with the common
picture seen in telephone-based surveys. Addition-
ally, respiratory allergy prevalence was higher
among young people.
Discussion
The study addressed patient perception only and
did not imply any objective disease parameter
accordingly as, e.g. positive skin prick testing or
the detection of allergen specific IgE. It was
therefore possible to use telephone-based survey
techniques and exploit a number of advantages
linked hereto.
The telephone statistics of this study demon-
strate that it is possible to obtain disease-specific
information by telephone interviewing techniques,
developed for and normally implied in election
polls or market surveys. In the case of respiratory
allergy, the sufferers were readily prepared to give
information over the phone as 85.4% of the
positively screened accepted to participate in the
25min long and two-phased study, when asked.
Additionally, as nearly 90% of the identified
perceived respiratory allergic respondents entering
the study completed both the 50-item question-
naire and the two-phased interviewing procedure,
it implied that the large set-up worked well.
For many years, the telephone survey techniques
have been standardised and refined in order to be
capable of obtaining information concerning the
perceptions and opinions of the general population
or specific sub-populations.9–11 Subsequently, the
techniques of today are sophisticated and much
scientific information is available about response
rates, reliability, cross-national comparisons and
mathematical data weighting. As telephone survey
techniques secure a low random sampling error, the
use of such techniques allows for identification of
truly random, national test populations, represen-
tative of sex, age and geographical distributions in
each country.
Alternative survey techniques do not possess the
same power in terms of selecting randomised and
national representative populations as they often
involve direct human contact, and subsequently
become restricted in relation to randomisation of
one or more parameters.
In general, it is difficult to assure representative
sampling, i.e. low random sampling error, as all
methods cause some limitation to the accessibility
of one or more sub-groups. In telephone surveys,
men and younger people are usually underrepre-
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Table 3 The distributions of unweighted and weighted entries by country
Total DK SF D I NL N E S GB
Number 7004 496 502 508 1001 1008 548 507 1002 499 994
Unweighted data
Female (%) 63 56 58 71 62 64 69 52 65 53 66
Male (%) 37 44 42 29 38 36 31 48 35 47 34
16–29 years (%) 34 34 30 28 27 36 28 26 53 32 29
30–49 years (%) 50 52 49 44 52 46 57 56 38 56 59
50–60 years (%) 16 15 21 28 21 18 14 17 9 12 11
Weighted data
Female (%) 53 50 53 58 44 51 51 53 54 47 53
Male (%) 47 50 47 42 56 49 49 47 46 53 48
16–29 years (%) 38 39 33 33 30 36 41 36 50 35 39
30–49 years (%) 46 46 46 49 48 46 48 47 39 42 47
50–60 years (%) 17 15 21 18 22 18 12 17 12 23 14
Weighting was done in relation to sex age, and relative weight of respiratory allergics.
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sented. The reasons for this are that the refusal
rate is commonly higher among men and that
younger people are more difficult to contact at
home. This picture was also seen in this study.
However, it was possible by means of a validated
mathematical weighting procedure to correct im-
balances and achieve the ideal distribution of each
country in terms of age and sex (Table 3).
The focus groups reported that family, physicians
and the society underestimate and neglect the
consequences of atopic respiratory diseases. This
could mask an appropriate assessment of the
extent of allergy-related problems, and subse-
quently hamper appropriate action as the allergic
patient may be less inclined to stand out. Many
different effects could derive from such attitude
and include patient denial and resultant delay in
consulting a physician, wrongful or lack of specific
allergy diagnosis, self-administration of OTC symp-
tomatic drugs, and subsequent underestimation or
ignorance of disease progression and consequences.
This study examined the use of and the con-
sequence for the allergic patient of diagnostic
testing, medical diagnosis and the prevalence of
patient perceived respiratory allergy at a European
level. Consequently, it was neither a criterion to
have had a medical diagnosis nor to have had a
specific allergy test. The AllergyFLiving & Learn-
ing populations established consisted of people who
reported that they were allergic to one or more
specific substances and who declared to be suffer-
ing from specific symptoms related to allergic
respiratory diseases. The inclusion was based on
the respondents’ reporting only, and hypochon-
driacs or subjects with a non-allergic disease could
potentially go through both the screening and the
interviewing phases. Nonetheless, questions eluci-
dating seasonal and diurnal variations in symptoms,
respiratory allergic substances, the use of medica-
tion and more, allowed an indirect verification of
the respiratory allergy by means of cross-tabula-
tion. These checkpoints minimised the bias poten-
tially introduced however, whenever in doubt,
about a specific respondent’s status, the respon-
dent was included.
For respiratory allergy, especially asthma, more
epidemiological studies have been and are being
conducted.12–14 Upon identification of a potential
participant, all implied methodologies include
more objective diagnostic tests such as SPT and
specific IgE test, and/or medical examination
verifying the diagnosis prior to inclusion. Such
thorough inclusion procedures ensure the status of
the individual included and are necessary when
purely medical problems are to be addressed.
Nonetheless, as in some European countries both
allergy specialist and allergy centres are very few,
the involvement of medical expertise may either
cause restrictions of the geographical representa-
tive status or prevent data collection.
In Europe, the allergy health-care systems vary
significantly between countries as do both the
definition of the allergic diseases and previously
reported national prevalence.13,15 Such differences
restrain comparisons between countries and poten-
tially cross-national optimisation of allergy care and
treatment. The methodology applied in this study
was standardised and worked well in the 10
European countries involved, and consequently a
homogenous data set was established for each
country making cross-national comparisons possible.
The telephone-based interviews were conducted
in accordance with the ethical standards set out
for the market survey industry, ESOMAR, assuring
respondents’ anonymity. Specifically, the respon-
dents were in contact with the interviewer by
telephone only. Anonymity is normal in
scientific research and clinical studies but may be
perceived differently by the participant when
there is a physical contact. Demanding a physical
contact may not just be limiting to the composition
of the population due to logistics, timing and
trouble involved but also due to the patient’s
perception of loosing anonymity and subsequently
integrity. For various reasons, some people may
deny contact to physicians and a medical diagnosis
and subsequently only feel comfortable with an
interviewing procedure that is considered non-
personal.
In conclusion, the telephone survey technique
implied enabled the simultaneous establishment of
national representative data sets from 10 European
countries. A questionnaire comprising approxi-
mately 50 question units and a two-phased inter-
viewing procedure worked satisfactorily. The data
have been collected in a database in which cross-
tabulations are unrestricted and any sub-group that
is identifiable by the questionnaire may be char-
acterised in detail.
Further analysis of data will focus on the
consequences of medical diagnosis and specific
testing to patient comprehension and management
of disease and on the potential cross-national
variation in allergy prevalence, perceived allergy
knowledge and the patient’s perceived need for
information.
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